Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ollila

Showing results (371-380 of 628) with videos related to

Pageof 63
Sort By:
The American Surgeon|September 30, 2017
Tumor Mitotic Rate and Association with Recurrence in Sentinel Lymph Node Negative Stage II Melanoma PatientsShachar Laks, Michael O Meyers, Allison M Deal, et al.
Clinical Lung Cancer|November 18, 2019
Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based ChemotherapyJuuso Paajanen, Ilkka Ilonen, Helena Lauri, et al.
The Journal of Investigative Dermatology|May 14, 2004
Tandem BRAF mutations in primary invasive melanomasNancy E Thomas, Audrey Alexander, Sharon N Edmiston, et al.
Journal of Neuroimmunology|January 8, 2018
Complex HLA association in paraneoplastic cerebellar ataxia with anti-Yo antibodiesRyan P Hillary, Hanna M Ollila, Ling Lin, et al.
JAMA Dermatology|December 11, 2024
Risk of Death Due to Melanoma and Other Causes in Patients With Thin Cutaneous MelanomasSerigne N Lo, Gabrielle J Williams, Anne E Cust, et al.
Breast Cancer Research and Treatment|June 27, 2021
Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patientsJeffrey E Johnson, Paula D Strassle, Guilherme C de Oliveira, et al.
Disease Models & Mechanisms|March 13, 2023
Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growthToni T Lemmetyinen, Emma W Viitala, Linnea Wartiovaara, et al.
Cancer Investigation|August 7, 2003
A phase I study of gemcitabine and docetaxel for advanced stage solid tumorsMichael E Poole, Stephen A Bernard, Mary Ann Churchel, et al.
Bioresource Technology|July 14, 2026
Protease suppression by native I9 inhibitor improves recombinant protein production in Trichoderma reeseiMari Valkonen, Mykhailo Girych, Sami Havukainen, et al.
Annals of Surgery|July 30, 2015
Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance)Mehra Golshan, Constance T Cirrincione, William M Sikov, et al.
Pageof 63

Showing results (371-380 of 628) with videos related to

Sort By:
Pageof 63
The American Surgeon|September 30, 2017
Tumor Mitotic Rate and Association with Recurrence in Sentinel Lymph Node Negative Stage II Melanoma PatientsShachar Laks, Michael O Meyers, Allison M Deal, et al.
Clinical Lung Cancer|November 18, 2019
Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based ChemotherapyJuuso Paajanen, Ilkka Ilonen, Helena Lauri, et al.
The Journal of Investigative Dermatology|May 14, 2004
Tandem BRAF mutations in primary invasive melanomasNancy E Thomas, Audrey Alexander, Sharon N Edmiston, et al.
Journal of Neuroimmunology|January 8, 2018
Complex HLA association in paraneoplastic cerebellar ataxia with anti-Yo antibodiesRyan P Hillary, Hanna M Ollila, Ling Lin, et al.
JAMA Dermatology|December 11, 2024
Risk of Death Due to Melanoma and Other Causes in Patients With Thin Cutaneous MelanomasSerigne N Lo, Gabrielle J Williams, Anne E Cust, et al.
Breast Cancer Research and Treatment|June 27, 2021
Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patientsJeffrey E Johnson, Paula D Strassle, Guilherme C de Oliveira, et al.
Disease Models & Mechanisms|March 13, 2023
Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growthToni T Lemmetyinen, Emma W Viitala, Linnea Wartiovaara, et al.
Cancer Investigation|August 7, 2003
A phase I study of gemcitabine and docetaxel for advanced stage solid tumorsMichael E Poole, Stephen A Bernard, Mary Ann Churchel, et al.
Bioresource Technology|July 14, 2026
Protease suppression by native I9 inhibitor improves recombinant protein production in Trichoderma reeseiMari Valkonen, Mykhailo Girych, Sami Havukainen, et al.
Annals of Surgery|July 30, 2015
Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance)Mehra Golshan, Constance T Cirrincione, William M Sikov, et al.
Pageof 63